Pancreatic Cancer Research

ResearcherUniversity of MichiganActive in the last 2 years

David Clement Whitcomb

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-4462-1410; OpenAlex author ID A5021037951; NIH RePORTER profile ID 78855489. Sources: OpenAlex.

Their work

Papers
22 (first author 1, last author 5)
Trials
0
Grants
10
Labs led
1
Collaborators
128
Papers, trials and grants by year

2011: 2 papers, 1 grant · 2012: 2 papers, 1 grant · 2013: 1 paper, 1 grant · 2014: 2 papers, 1 grant · 2015: 2 papers, 1 grant · 2016: 2 papers · 2017: none · 2018: 6 papers, 1 grant · 2019: 2 papers, 1 grant · 2020: 2 papers · 2021: 1 grant · 2022: none · 2023: none · 2024: 1 grant · 2025: 1 paper · 2026: 1 grant

Papers 22

  1. Genetic testing for pancreatic cancer screening: ready for prime time? Co-author DOI 10.1097/mog.0000000000001121↗
  2. Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and w… Co-author DOI 10.1016/j.pan.2019.11.008↗
  3. International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international … Co-author DOI 10.1016/j.pan.2020.05.011↗
  4. Surveillance for pancreatic cancer in high-risk individuals. Co-author DOI 10.1002/bjs5.50180↗
  5. Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer. Last author DOI 10.1097/mpa.0000000000001335↗
  6. Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer. Last author DOI 10.1038/s41395-018-0194-5↗
  7. Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts. Last author DOI 10.1097/mpa.0000000000001136↗
  8. Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rational… Co-author DOI 10.1097/mpa.0000000000001168↗
  9. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the … Co-author DOI 10.1097/mpa.0000000000001170↗
  10. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pan… Co-author DOI 10.1097/mpa.0000000000001171↗
  11. Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier Age. Co-author DOI 10.1155/2018/2380596↗
  12. Increased Serum Insulin Exposure Does Not Affect Age or Stage of Pancreatic Adenocarcinoma Diagnosis in Patients With Diabetes Mellitus. Co-author DOI 10.1097/mpa.0000000000000439↗
  13. Pancreatic Cancer Chemoprevention Translational Workshop: Meeting Report. Co-author DOI 10.1097/mpa.0000000000000705↗
  14. Genetics and Genetic Testing in Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2015.07.057↗
  15. Distribution of cholecystokinin-B receptor genotype between patients with pancreatic cancer and controls and its impact on survival. First author DOI 10.1097/mpa.0000000000000263↗
  16. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer. Co-author DOI 10.1016/j.cgh.2014.02.038↗
  17. Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model. Co-author DOI 10.1080/01635581.2013.795979↗
  18. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Last author DOI 10.1097/mpa.0b013e3182a9ad9d↗
  19. Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: a multicenter study. Co-author DOI 10.1038/ajg.2012.288↗
  20. Inherited pancreatic cancer syndromes. Last author DOI 10.1097/ppo.0b013e318278c4a6↗
  21. Serum biomarker panels for the detection of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-10-0248↗
  22. PCCR: Pancreatic Cancer Collaborative Registry. Co-author DOI 10.4137/cin.s6919↗

Grants 10

  1. UPMC Clinical Center for the Study of Chronic Pancreatitis and Diabetes U01DK108306↗
  2. The Ohio State University Chronic Pancreatitis Diabetes Pancreas Cancer (CPDPC) Clinical Center U01DK108327↗
  3. PancreasFest 2021 R13DK130515↗
  4. PancreasFest 2019: Team Science for complex Pancreatic Diseases and Pancreatic Cancer: Goals, Milestones and Methods R13DK122825↗
  5. PancreasFest 2018 Early Diagnosis and Treatment of Pancreatitis, Pancreatic Diabetes and Pancreatic Cancer R13DK118902↗
  6. PancreasFest 2015: Applying Research Discoveries in Pancreatitis & Pancreatic Cancer to Patient-Centered Care R13DK107248↗
  7. PancreasFest 2014: Risks and Mechanisms of Pancreatitis and Pancreatic Diabetes R13DK103527↗
  8. PancreasFest 2013: Risk, Progression & Therapeutic Advances in Acute Pancreatitis R13DK100242↗
  9. Pancreasfest 2012 Pancreatic Cancer: Risk, Early Detection, Diagnosis & Treatment R13DK096904↗
  10. NAPS2 Continuation Genome Wide Association Study of Pancreatitis R56DK061451↗

Closest collaborators

The 25 strongest of 128 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Randall E. Brand · 15 shared papers, 1 shared grant, 2011–2026 · strength 1.76
  2. Dhiraj Yadav · 6 shared papers, 1 shared grant, 2018–2026 · strength 1.33
  3. Frederico G. S. Toledo · 1 shared grant, 2026 · strength 0.86
  4. Darwin Lewis Conwell · 3 shared papers, 1 shared grant, 2014–2024 · strength 0.54
  5. Mark D. Topazian · 2 shared papers, 1 shared grant, 2018–2024 · strength 0.51
  6. Melena D. Bellin · 1 shared paper, 1 shared grant, 2018–2024 · strength 0.45
  7. Hanno Steen · 1 shared paper, 1 shared grant, 2018–2024 · strength 0.45
  8. Philip A. Hart · 1 shared grant, 2024 · strength 0.39
  9. Andres Gelrud · 1 shared grant, 2024 · strength 0.39
  10. Pamela G. Banks · 1 shared grant, 2024 · strength 0.39
  11. Cheryl E Gariepy · 1 shared grant, 2024 · strength 0.39
  12. Francis G Gress · 1 shared grant, 2024 · strength 0.39
  13. Joseph Palermo · 1 shared grant, 2024 · strength 0.39
  14. Peter Alan Banks · 1 shared grant, 2024 · strength 0.39
  15. Celeste A. Shelton · 3 shared papers, 2015–2018 · strength 0.29
  16. Aida Habtezion · 3 shared papers, 2018–2020 · strength 0.23
  17. Sudhir Srivastava · 4 shared papers, 2016–2018 · strength 0.22
  18. Jo Ann Rinaudo · 4 shared papers, 2016–2018 · strength 0.22
  19. Steven J. Hughes · 3 shared papers, 2018–2020 · strength 0.22
  20. Dana K. Andersen · 3 shared papers, 2013–2020 · strength 0.21
  21. Stephen Jacob Pandol · 3 shared papers, 2018–2019 · strength 0.19
  22. Suresh T. Chari · 3 shared papers, 2016–2020 · strength 0.19
  23. José Serrano · 3 shared papers, 2018 · strength 0.18
  24. Phil A. Hart · 3 shared papers, 2018 · strength 0.18
  25. Herbert J. Zeh · 3 shared papers, 2011–2018 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.